Global Intranasal Corticosteroids Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: GAF2B8B97013EN
QYResearch

Abstracts

This report focuses on the global Intranasal Corticosteroids status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Intranasal Corticosteroids development in North America, Europe and Asia-Pacific.
The key players covered in this study

• GlaxoSmithKline
• Merck
• Sanofi
• SUMITOMO
• Teva
• Johnson & Johnson
• AstraZeneca

Market segment by Type, the product can be split into

• Prescribed Drugs
• OTC Drugs

Market segment by Application, split into

• Hospital Pharmacies
• Online Pharnacies
• Retail Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Intranasal Corticosteroids status, future forecast, growth opportunity, key market and key players.
• To present the Intranasal Corticosteroids development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Intranasal Corticosteroids are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Intranasal Corticosteroids Revenue
1.4 Market Analysis by Type
  1.4.1 Global Intranasal Corticosteroids Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Prescribed Drugs
  1.4.3 OTC Drugs
1.5 Market by Application
  1.5.1 Global Intranasal Corticosteroids Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Online Pharnacies
  1.5.4 Retail Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Intranasal Corticosteroids Industry Impact
  1.6.1 How the Covid-19 is Affecting the Intranasal Corticosteroids Industry
    1.6.1.1 Intranasal Corticosteroids Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Intranasal Corticosteroids Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Intranasal Corticosteroids Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Intranasal Corticosteroids Market Perspective (2015-2026)
2.2 Intranasal Corticosteroids Growth Trends by Regions
  2.2.1 Intranasal Corticosteroids Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Intranasal Corticosteroids Historic Market Share by Regions (2015-2020)
  2.2.3 Intranasal Corticosteroids Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Intranasal Corticosteroids Market Growth Strategy
  2.3.6 Primary Interviews with Key Intranasal Corticosteroids Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Intranasal Corticosteroids Players by Market Size
  3.1.1 Global Top Intranasal Corticosteroids Players by Revenue (2015-2020)
  3.1.2 Global Intranasal Corticosteroids Revenue Market Share by Players (2015-2020)
  3.1.3 Global Intranasal Corticosteroids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Intranasal Corticosteroids Market Concentration Ratio
  3.2.1 Global Intranasal Corticosteroids Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Intranasal Corticosteroids Revenue in 2019
3.3 Intranasal Corticosteroids Key Players Head office and Area Served
3.4 Key Players Intranasal Corticosteroids Product Solution and Service
3.5 Date of Enter into Intranasal Corticosteroids Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Intranasal Corticosteroids Historic Market Size by Type (2015-2020)
4.2 Global Intranasal Corticosteroids Forecasted Market Size by Type (2021-2026)

5 INTRANASAL CORTICOSTEROIDS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Intranasal Corticosteroids Market Size by Application (2015-2020)
5.2 Global Intranasal Corticosteroids Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Intranasal Corticosteroids Market Size (2015-2020)
6.2 Intranasal Corticosteroids Key Players in North America (2019-2020)
6.3 North America Intranasal Corticosteroids Market Size by Type (2015-2020)
6.4 North America Intranasal Corticosteroids Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Intranasal Corticosteroids Market Size (2015-2020)
7.2 Intranasal Corticosteroids Key Players in Europe (2019-2020)
7.3 Europe Intranasal Corticosteroids Market Size by Type (2015-2020)
7.4 Europe Intranasal Corticosteroids Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Intranasal Corticosteroids Market Size (2015-2020)
8.2 Intranasal Corticosteroids Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Intranasal Corticosteroids Market Size by Type (2015-2020)
8.4 Asia-Pacific Intranasal Corticosteroids Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 GlaxoSmithKline
  9.1.1 GlaxoSmithKline Company Details
  9.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
  9.1.3 GlaxoSmithKline Intranasal Corticosteroids Introduction
  9.1.4 GlaxoSmithKline Revenue in Intranasal Corticosteroids Business (2015-2020))
  9.1.5 GlaxoSmithKline Recent Development
9.2 Merck
  9.2.1 Merck Company Details
  9.2.2 Merck Business Overview and Its Total Revenue
  9.2.3 Merck Intranasal Corticosteroids Introduction
  9.2.4 Merck Revenue in Intranasal Corticosteroids Business (2015-2020)
  9.2.5 Merck Recent Development
9.3 Sanofi
  9.3.1 Sanofi Company Details
  9.3.2 Sanofi Business Overview and Its Total Revenue
  9.3.3 Sanofi Intranasal Corticosteroids Introduction
  9.3.4 Sanofi Revenue in Intranasal Corticosteroids Business (2015-2020)
  9.3.5 Sanofi Recent Development
9.4 SUMITOMO
  9.4.1 SUMITOMO Company Details
  9.4.2 SUMITOMO Business Overview and Its Total Revenue
  9.4.3 SUMITOMO Intranasal Corticosteroids Introduction
  9.4.4 SUMITOMO Revenue in Intranasal Corticosteroids Business (2015-2020)
  9.4.5 SUMITOMO Recent Development
9.5 Teva
  9.5.1 Teva Company Details
  9.5.2 Teva Business Overview and Its Total Revenue
  9.5.3 Teva Intranasal Corticosteroids Introduction
  9.5.4 Teva Revenue in Intranasal Corticosteroids Business (2015-2020)
  9.5.5 Teva Recent Development
9.6 Johnson & Johnson
  9.6.1 Johnson & Johnson Company Details
  9.6.2 Johnson & Johnson Business Overview and Its Total Revenue
  9.6.3 Johnson & Johnson Intranasal Corticosteroids Introduction
  9.6.4 Johnson & Johnson Revenue in Intranasal Corticosteroids Business (2015-2020)
  9.6.5 Johnson & Johnson Recent Development
9.7 AstraZeneca
  9.7.1 AstraZeneca Company Details
  9.7.2 AstraZeneca Business Overview and Its Total Revenue
  9.7.3 AstraZeneca Intranasal Corticosteroids Introduction
  9.7.4 AstraZeneca Revenue in Intranasal Corticosteroids Business (2015-2020)
  9.7.5 AstraZeneca Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Intranasal Corticosteroids Key Market Segments
Table 2. Key Players Covered: Ranking by Intranasal Corticosteroids Revenue
Table 3. Ranking of Global Top Intranasal Corticosteroids Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Intranasal Corticosteroids Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Prescribed Drugs
Table 6. Key Players of OTC Drugs
Table 7. COVID-19 Impact Global Market: (Four Intranasal Corticosteroids Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Intranasal Corticosteroids Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Intranasal Corticosteroids Players to Combat Covid-19 Impact
Table 12. Global Intranasal Corticosteroids Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Intranasal Corticosteroids Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Intranasal Corticosteroids Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Intranasal Corticosteroids Market Share by Regions (2015-2020)
Table 16. Global Intranasal Corticosteroids Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Intranasal Corticosteroids Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Intranasal Corticosteroids Market Growth Strategy
Table 22. Main Points Interviewed from Key Intranasal Corticosteroids Players
Table 23. Global Intranasal Corticosteroids Revenue by Players (2015-2020) (Million US$)
Table 24. Global Intranasal Corticosteroids Market Share by Players (2015-2020)
Table 25. Global Top Intranasal Corticosteroids Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intranasal Corticosteroids as of 2019)
Table 26. Global Intranasal Corticosteroids by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Intranasal Corticosteroids Product Solution and Service
Table 29. Date of Enter into Intranasal Corticosteroids Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Intranasal Corticosteroids Market Size by Type (2015-2020) (Million US$)
Table 32. Global Intranasal Corticosteroids Market Size Share by Type (2015-2020)
Table 33. Global Intranasal Corticosteroids Revenue Market Share by Type (2021-2026)
Table 34. Global Intranasal Corticosteroids Market Size Share by Application (2015-2020)
Table 35. Global Intranasal Corticosteroids Market Size by Application (2015-2020) (Million US$)
Table 36. Global Intranasal Corticosteroids Market Size Share by Application (2021-2026)
Table 37. North America Key Players Intranasal Corticosteroids Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Intranasal Corticosteroids Market Share (2019-2020)
Table 39. North America Intranasal Corticosteroids Market Size by Type (2015-2020) (Million US$)
Table 40. North America Intranasal Corticosteroids Market Share by Type (2015-2020)
Table 41. North America Intranasal Corticosteroids Market Size by Application (2015-2020) (Million US$)
Table 42. North America Intranasal Corticosteroids Market Share by Application (2015-2020)
Table 43. Europe Key Players Intranasal Corticosteroids Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Intranasal Corticosteroids Market Share (2019-2020)
Table 45. Europe Intranasal Corticosteroids Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Intranasal Corticosteroids Market Share by Type (2015-2020)
Table 47. Europe Intranasal Corticosteroids Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Intranasal Corticosteroids Market Share by Application (2015-2020)
Table 49. Asia-Pacific Key Players Intranasal Corticosteroids Revenue (2019-2020) (Million US$)
Table 50. Asia-Pacific Key Players Intranasal Corticosteroids Market Share (2019-2020)
Table 51. Asia-Pacific Intranasal Corticosteroids Market Size by Type (2015-2020) (Million US$)
Table 52. Asia-Pacific Intranasal Corticosteroids Market Share by Type (2015-2020)
Table 53. Asia-Pacific Intranasal Corticosteroids Market Size by Application (2015-2020) (Million US$)
Table 54. Asia-Pacific Intranasal Corticosteroids Market Share by Application (2015-2020)
Table 55. GlaxoSmithKline Company Details
Table 56. GlaxoSmithKline Business Overview
Table 57. GlaxoSmithKline Product
Table 58. GlaxoSmithKline Revenue in Intranasal Corticosteroids Business (2015-2020) (Million US$)
Table 59. GlaxoSmithKline Recent Development
Table 60. Merck Company Details
Table 61. Merck Business Overview
Table 62. Merck Product
Table 63. Merck Revenue in Intranasal Corticosteroids Business (2015-2020) (Million US$)
Table 64. Merck Recent Development
Table 65. Sanofi Company Details
Table 66. Sanofi Business Overview
Table 67. Sanofi Product
Table 68. Sanofi Revenue in Intranasal Corticosteroids Business (2015-2020) (Million US$)
Table 69. Sanofi Recent Development
Table 70. SUMITOMO Company Details
Table 71. SUMITOMO Business Overview
Table 72. SUMITOMO Product
Table 73. SUMITOMO Revenue in Intranasal Corticosteroids Business (2015-2020) (Million US$)
Table 74. SUMITOMO Recent Development
Table 75. Teva Company Details
Table 76. Teva Business Overview
Table 77. Teva Product
Table 78. Teva Revenue in Intranasal Corticosteroids Business (2015-2020) (Million US$)
Table 79. Teva Recent Development
Table 80. Johnson & Johnson Company Details
Table 81. Johnson & Johnson Business Overview
Table 82. Johnson & Johnson Product
Table 83. Johnson & Johnson Revenue in Intranasal Corticosteroids Business (2015-2020) (Million US$)
Table 84. Johnson & Johnson Recent Development
Table 85. AstraZeneca Company Details
Table 86. AstraZeneca Business Overview
Table 87. AstraZeneca Product
Table 88. AstraZeneca Revenue in Intranasal Corticosteroids Business (2015-2020) (Million US$)
Table 89. AstraZeneca Recent Development
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Intranasal Corticosteroids Market Share by Type: 2020 VS 2026
Figure 2. Prescribed Drugs Features
Figure 3. OTC Drugs Features
Figure 4. Global Intranasal Corticosteroids Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Online Pharnacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Intranasal Corticosteroids Report Years Considered
Figure 9. Global Intranasal Corticosteroids Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Intranasal Corticosteroids Market Share by Regions: 2020 VS 2026
Figure 11. Global Intranasal Corticosteroids Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Intranasal Corticosteroids Market Share by Players in 2019
Figure 14. Global Top Intranasal Corticosteroids Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intranasal Corticosteroids as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Intranasal Corticosteroids Revenue in 2019
Figure 16. North America Intranasal Corticosteroids Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Intranasal Corticosteroids Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Asia-Pacific Intranasal Corticosteroids Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 20. GlaxoSmithKline Revenue Growth Rate in Intranasal Corticosteroids Business (2015-2020)
Figure 21. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Merck Revenue Growth Rate in Intranasal Corticosteroids Business (2015-2020)
Figure 23. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Sanofi Revenue Growth Rate in Intranasal Corticosteroids Business (2015-2020)
Figure 25. SUMITOMO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. SUMITOMO Revenue Growth Rate in Intranasal Corticosteroids Business (2015-2020)
Figure 27. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Teva Revenue Growth Rate in Intranasal Corticosteroids Business (2015-2020)
Figure 29. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Johnson & Johnson Revenue Growth Rate in Intranasal Corticosteroids Business (2015-2020)
Figure 31. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. AstraZeneca Revenue Growth Rate in Intranasal Corticosteroids Business (2015-2020)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed